In the complex real-world setting, potential interactions between confounding factors and hormones, including androgen-thyroid hormone and adipose tissue–prostate cancer interactions, contribute to the complex hormonal microenvironment of prostate cancer, thereby influencing the response to subsequent endocrine therapy (44, 45). Here, TG is linked to prostate carcinoma.